T-Cell Response to TB Infection: High-Resolution Imaging Reveals Major Differences Between Lab and Live Results.
Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.
An ancient disease, TB remains one of the major causes of disability and death worldwide. One third of the world’s population is infected with TB. Each year, more than 9 million people around the world become sick with TB and there are almost 2 million TB-related deaths. NIAID is examining TB at its fundamental levels through research aimed at developing faster diagnostic tools, better vaccines, and shorter treatment times. More about NIAID TB Research and Scientific Findings.
Multidrug-resistant and Extensively Drug-resistant Tuberculosis Research Agenda (PDF)
NIAID’s Role in Addressing TB, Drug-Resistant TB, and TB in People with HIV/AIDS
NIH-Funded HIV Clinical Research Sites to Join Pediatric TB Vaccine Study—Jan. 31, 2012
NIAID Media Availability: New TB Vaccine Approach Shows Promise in Mice—Sept. 6, 2011
World TB Day—March 24, 2011
Media Availability: Collaboration Fuels Promising New Approach to a TB Vaccine—Jan. 25, 2011
All TB News Releases
News from NIAID-Supported Institutions
Last Updated January 31, 2012
